Safety Study of of Intravenous CCL2-LPM in Patients With IgA Nephropathy
Clinical trial NCT00856674 · TERMINATED
Trial details
- NCT number
- NCT00856674
- Sponsor
- Osprey Pharmaceuticals USA, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2010-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.